The Company is in advanced stages of negotiating a collaboration with a USA-based Medical Group to support a highly cost-effective pathway for the necessary clinical trials.
I imagine that next week things will pick up. Easter break is over and the new financial year starts. Perhaps there will be lots of ISA capital flowing in here?